Picture of Stratec SE logo

SBS Stratec SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Brief: Stratec Aims For Constant-Currency CAGR Of 6.0% To 8.0% For Period Through To 2028

April 28 (Reuters) - STRATEC SE SBSG.DE:

REPORTS 2025 ADJUSTED EBIT MARGIN OF 10.0%, MEETING FORECAST

PROPOSES DIVIDEND OF €0.60 PER SHARE FOR 2025

OUTLOOK 2026: EBIT MARGIN EXPECTED TO APPROXIMATE TO PREVIOUS YEAR'S LEVEL (2025: 10.0%)

OUTLOOK 2026: SALES GROWTH WILL PREDOMINANTLY MATERIALIZE IN SECOND HALF OF 2026

OUTLOOK 2026: FIRST QUARTER IS EXPECTED TO SEE A SHARP REDUCTION IN SALES

FOR PERIOD 2029 TO 2030, GROWTH MOMENTUM IS EXPECTED TO INCREASE TO A CONSTANT-CURRENCY CAGR OF 10.0% TO 12.0%

FY CONSOLIDATED SALES OF EUR 250.9 MILLION REMAINED VIRTUALLY STABLE IN 2025 (PREVIOUS YEAR: EUR 257.6 MILLION)

OUTLOOK: FOR PERIOD THROUGH TO 2028 STRATEC AIMS TO ACHIEVE ANNUAL AVERAGE SALES GROWTH (CAGR) ON A CONSTANT-CURRENCY BASIS OF 6.0% TO 8.0%

OUTLOOK: ADJUSTED EBIT MARGIN SHOULD RISE TO AT LEAST 13.0% BY 2028 AND TO AT LEAST 15.0% BY 2030

Source text: ID:nEQ50dFgva

Further company coverage: SBSG.DE

 (Gdansk Newsroom)

 ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))

Recent news on Stratec SE

See all news